Annual ROE
-294.04%
+50.63%+14.69%
December 31, 2023
Summary
- As of February 12, 2025, TSHA annual return on equity is -294.04%, with the most recent change of +50.63% (+14.69%) on December 31, 2023.
- During the last 3 years, TSHA annual ROE has fallen by -270.16% (-1131.32%).
- TSHA annual ROE is now -1131.32% below its all-time high of -23.88%, reached on December 31, 2020.
Performance
TSHA ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-41.05%
+336.48%+89.13%
September 30, 2024
Summary
- As of February 12, 2025, TSHA quarterly return on equity is -41.05%, with the most recent change of +336.48% (+89.13%) on September 30, 2024.
- Over the past year, TSHA quarterly ROE has dropped by -896.65% (-104.80%).
- TSHA quarterly ROE is now -102.41% below its all-time high of 1700.77%, reached on December 31, 2023.
Performance
TSHA Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
TSHA ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +14.7% | -104.8% |
| 3 y3 years | -1131.3% | +42.3% |
| 5 y5 years | - | - |
TSHA ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -60.7% | +14.7% | -102.4% | +98.1% |
| 5 y | 5-year | -1131.3% | +14.7% | -102.4% | +98.1% |
| alltime | all time | -1131.3% | +14.7% | -102.4% | +98.1% |
Taysha Gene Therapies ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -41.05%(-89.1%) |
| Jun 2024 | - | -377.53%(-82.3%) |
| Mar 2024 | - | -2137.00%(-225.6%) |
| Dec 2023 | -294.04%(-14.7%) | 1700.77%(+98.8%) |
| Sep 2023 | - | 855.60%(-30.9%) |
| Jun 2023 | - | 1238.65%(-169.3%) |
| Mar 2023 | - | -1787.30%(+157.1%) |
| Dec 2022 | -344.67% | -695.27%(+104.7%) |
| Sep 2022 | - | -339.73%(+45.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | -233.05%(+42.9%) |
| Mar 2022 | - | -163.06%(+50.7%) |
| Dec 2021 | -182.97%(+666.2%) | -108.21%(+52.1%) |
| Sep 2021 | - | -71.13%(+55.3%) |
| Jun 2021 | - | -45.81%(-3.1%) |
| Mar 2021 | - | -47.26%(+33.9%) |
| Dec 2020 | -23.88% | - |
| Dec 2020 | - | -35.29%(+6.7%) |
| Sep 2020 | - | -33.07%(-110.4%) |
| Jun 2020 | - | 316.53% |
FAQ
- What is Taysha Gene Therapies annual return on equity?
- What is the all time high annual ROE for Taysha Gene Therapies?
- What is Taysha Gene Therapies annual ROE year-on-year change?
- What is Taysha Gene Therapies quarterly return on equity?
- What is the all time high quarterly ROE for Taysha Gene Therapies?
- What is Taysha Gene Therapies quarterly ROE year-on-year change?
What is Taysha Gene Therapies annual return on equity?
The current annual ROE of TSHA is -294.04%
What is the all time high annual ROE for Taysha Gene Therapies?
Taysha Gene Therapies all-time high annual return on equity is -23.88%
What is Taysha Gene Therapies annual ROE year-on-year change?
Over the past year, TSHA annual return on equity has changed by +50.63% (+14.69%)
What is Taysha Gene Therapies quarterly return on equity?
The current quarterly ROE of TSHA is -41.05%
What is the all time high quarterly ROE for Taysha Gene Therapies?
Taysha Gene Therapies all-time high quarterly return on equity is 1700.77%
What is Taysha Gene Therapies quarterly ROE year-on-year change?
Over the past year, TSHA quarterly return on equity has changed by -896.65% (-104.80%)